Rabi Hanna - Cell & Gene therapy Doc
@rabihannamd.bsky.social did:plc:bv356wcjbcdymwzuipl5nz6h
Chief of Pediatric hem-Onc & BMT @ClevelandClinic #CleClinicCancer @cleclinickids #CleClinicPedsCancer #ChildhoodCancer #pedcsm #bmtsm. Posts are my own opinion.
En Bluesky desde el
- Seguidores
- 245
- Siguiendo
- 51
- Posts
- 53
- Días en rankings
- 0
Resumen
Rabi Hanna - Cell & Gene therapy Doc (@rabihannamd.bsky.social) es un usuario de Bluesky que se unió el 27 noviembre 2024. Tiene 245 seguidores, sigue a 51 cuentas y ha publicado 53 posts.
Apariciones en rankings
Los mejores días en que los posts de esta cuenta entraron en la lista diaria de Debya.
Esta cuenta aún no ha aparecido en un ranking diario.
Posts que le gustaron recientemente
Me gusta públicos de la red Bluesky.
www.nejm.org/doi/full/10.... www.nejm.org/doi/full/10.... www.nejm.org/doi/full/10.... @harvardmed.bsky.social @clevelandclinic.bsky.social @drheeney.bsky.social @hfrangoul.bsky.social @rabihannamd.bsky.social
Ver post#ASH25 #bmtsm Kim: of those with cGVHD 54% steroid refractory, 96% of whom recd Rux and few went on to need later lines of therapy. 2yr OS 85% with Haplo, 82% MUD, 77% MMUD. NRM 7-10% for Haplo/MUD, 16% with MMUD.
Ver post#ASH25 #bmtsm Soiffer: although cGVHD reduced overall, this benefit of cryo was not seen in pts getting PTCy. Given higher OS in spite of lower GRFS with cryo, fresh grafts remain the preferred standard (but still reasonable when logistically useful).
Ver postHear about Dr. Storb’s impact on #Hematology: m.youtube.com/watch?v=302N... #ASH25 #HemeSky
Ver post#ASH25 #leusm Miltiadous: Higher pre-HCT gut flora diversity associated with improved post-HCT survival in adults. Here, 327 peds ongoing first allo were evaluated, but all slides requested no reposting so I can’t share with you. 🤷🏻♂️
Ver post
Cuentas que bloquea
En Bluesky los bloqueos son registros públicos.
Esta cuenta no bloquea a nadie.